Atrial Fibrillation and Heart Failure: Untangling a Modern Gordian Knot

Allan C Skanes1, Anthony S L Tang1

  • 1London Heart Rhythm Program, Western University, London, Ontario, Canada.

Insights

Heart failure (HF) and atrial fibrillation (AF) often coexist, increasing mortality. Catheter ablation to restore sinus rhythm shows promise for improving HF symptoms and function, though long-term outcomes require further study.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Heart failure (HF) and atrial fibrillation (AF) are prevalent, especially in aging populations, with combined mortality significantly higher than individual conditions.
  • A complex interplay exists between AF and HF, involving shared risk factors and intertwined pathophysiological mechanisms.
  • Asymptomatic left ventricular dysfunction can worsen or be worsened by AF, leading to HF with reduced ejection fraction (HFrEF) or HF with preserved ejection fraction (HFpEF).

Purpose of the Study:

  • To review the relationship between AF and HF, focusing on pathophysiology and treatment strategies.
  • To evaluate the impact of restoring sinus rhythm on HF outcomes, particularly concerning catheter ablation versus pharmacological approaches.

Main Methods:

  • Review of existing literature on the pathophysiology and management of coexisting AF and HF.
  • Analysis of recent studies investigating the efficacy of catheter ablation for achieving sinus rhythm in HF patients.
  • Comparison of outcomes between pharmacological rhythm control and catheter ablation in HF populations.

Main Results:

  • Pharmacological restoration of sinus rhythm has not demonstrated significant improvements in cardiovascular or total mortality for HF patients.
  • Recent studies suggest catheter ablation to achieve sinus rhythm may significantly improve symptoms, cardiac function, and potentially reduce mortality in HF patients.
  • The long-term prognostic impact of catheter ablation on HF outcomes remains under investigation.

Conclusions:

  • While traditional treatments have improved quality of life for HF patients, prognosis alteration remains limited.
  • Catheter ablation for AF in HF patients presents a promising strategy for improving clinical outcomes and cardiac function.
  • Further research is needed to definitively establish the long-term benefits and optimal role of catheter ablation in managing HF.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.9K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971